Business Description
Dyadic International Inc
NAICS : 325414
SIC : 2836
Description
Dyadic International Inc is a global biotechnology platform company. The company has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins, and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.79 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 1.98 | |||||
| Beneish M-Score | 0 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 22.3 | |||||
| 3-Year EBITDA Growth Rate | -24.3 | |||||
| 3-Year EPS without NRI Growth Rate | -30.8 | |||||
| 3-Year FCF Growth Rate | -36.6 | |||||
| 3-Year Book Growth Rate | -25.7 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 49.94 | |||||
| 9-Day RSI | 37.67 | |||||
| 14-Day RSI | 34.65 | |||||
| 6-1 Month Momentum % | -19.28 | |||||
| 12-1 Month Momentum % | -50.28 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.98 | |||||
| Quick Ratio | 4.98 | |||||
| Cash Ratio | 4.6 | |||||
| Days Sales Outstanding | 48.38 | |||||
| Days Payable | 326.96 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -1.9 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 33.42 | |||||
| Operating Margin % | -585.43 | |||||
| Net Margin % | -506.23 | |||||
| ROE % | -62.68 | |||||
| ROA % | -54.53 | |||||
| ROIC % | -1193.04 | |||||
| ROCE % | -71.77 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shiller PE Ratio | 46.58 | |||||
| PS Ratio | 23.54 | |||||
| PB Ratio | 4.02 | |||||
| Price-to-Tangible-Book | 3.94 | |||||
| EV-to-EBIT | -2.89 | |||||
| EV-to-EBITDA | -2.89 | |||||
| EV-to-Forward-EBITDA | -19.14 | |||||
| EV-to-Revenue | 16.92 | |||||
| EV-to-Forward-Revenue | 2.32 | |||||
| EV-to-FCF | -3.28 | |||||
| Price-to-Median-PS-Value | 0.38 | |||||
| Price-to-Net-Current-Asset-Value | 4.02 | |||||
| Price-to-Net-Cash | 4.5 | |||||
| Earnings Yield (Greenblatt) % | -34.59 |
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:DYAI
Executives
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 2.313 | ||
| EPS (TTM) ($) | -0.42 | ||
| Beta | 0.2 | ||
| Volatility % | 59.42 | ||
| 14-Day RSI | 34.65 | ||
| 14-Day ATR ($) | 0.173199 | ||
| 20-Day SMA ($) | 2.18125 | ||
| 12-1 Month Momentum % | -50.28 | ||
| 52-Week Range ($) | 1.65 - 5.64 | ||
| Shares Outstanding (Mil) | 28.42 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Dyadic International Inc Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||
Dyadic International Inc Analysis
Share your researchHeadlines
See More
No news.